Trial Profile
An effect of co-administration of Interferon and Sorafenib in patients with recurrent advanced hepatitis C-related hepatocellular carcinoma.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Jun 2016
Price :
$35
*
At a glance
- Drugs Interferon (Primary) ; Sorafenib (Primary)
- Indications Hepatitis C; Liver cancer
- Focus Therapeutic Use
- 23 Jun 2016 New trial record
- 24 May 2016 Results presented at the Digestive Disease Week 2016